RA

Rheumatoid Arthritis Increases Risk For Cardiovascular, All-Cause Mortality in End-Stage Renal Disease

Rheumatoid Arthritis Increases Risk For Cardiovascular, All-Cause Mortality in End-Stage Renal Disease

By

Patients with rheumatoid arthritis and end-stage renal disease have an increased risk for cardiovascular-related death compared with patients without rheumatoid arthritis.

No Negative Effect on Disease Activity Seen in Switching Patients to Biosimilar Infliximab From Originator Drug

No Negative Effect on Disease Activity Seen in Switching Patients to Biosimilar Infliximab From Originator Drug

By

Researchers found similar disease duration the 3 months before and after the switch to CT-P13 in patients.

Low Disease Activity After Tofacitinib Discontinuation in Rheumatoid Arthritis

Low Disease Activity After Tofacitinib Discontinuation in Rheumatoid Arthritis

By

Researchers found that one-third of patients remain in remission after discontinuing tofacitinib and that low baseline RF titers predict low disease activity after tofacitinib discontinuation.

Rheumatoid Arthritis Disease Progression on MRI Despite Clinical Improvement

Rheumatoid Arthritis Disease Progression on MRI Despite Clinical Improvement

By

MRI is more sensitive than clinical markers for identifying radiographic disease progression.

Sign Up for Free e-newsletters